Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA ...

On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...

Alzheimer's disease is a type of dementia, but not all dementia is Alzheimer's. Dementia symptoms include memory loss, problem-solving trouble, and trouble completing tasks. Seeking early diagnosis ...

Gait disturbances are a prevalent issue in individuals with neurological disorders, affecting millions worldwide. These disorders, including Parkinson's ...

Leqembi (lecanemab-irmb) is a prescription drug that’s used to treat Alzheimer’s disease. It does not cure Alzheimer’s disease, but may help slow its progression. It comes as a liquid solution that ...